26 related articles for article (PubMed ID: 27668530)
1. Management of metastatic bone disease of melanoma.
Chen W; Yang C; Chen B; Xi M; Chen B; Li Q
Melanoma Res; 2024 Feb; 34(1):22-30. PubMed ID: 37939058
[TBL] [Abstract][Full Text] [Related]
2. BONE MARKERS IN ARTHROPATHIES.
Răduț R; Crăciun AM; Silaghi CN
Acta Clin Croat; 2019 Dec; 58(4):716-725. PubMed ID: 32595257
[TBL] [Abstract][Full Text] [Related]
3. [The possibility of the serum concentration of osteocalcin determination in lung cancer patients with suspected bone metastases].
Weissensteiner J; Babušíková E
Klin Onkol; 2015; 28(1):51-6. PubMed ID: 25692755
[TBL] [Abstract][Full Text] [Related]
4. The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients.
Weissensteiner J; Babusikova E
Neoplasma; 2019 Nov; 66(6):1024-1030. PubMed ID: 31307200
[TBL] [Abstract][Full Text] [Related]
5. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies using measurement of N-telopeptides of type 1 collagen (NTx) in patients with bone metastasis--comparison with bone scintigraphy and other metabolic bone markers].
Yamamoto I; Morita R; Konishi J; Shigeno C; Ikekubo K; Hino M; Sone T; Fujimoto R
Kaku Igaku; 1995 May; 32(5):501-10. PubMed ID: 7596071
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
8. Bone Metabolism of the Patient with a Malignant Melanoma during the Entry Examination and the Check-up of Whole-body Bone Scintigraphy.
Weissensteiner J; Babušíková E
Prague Med Rep; 2016; 117(2-3):129-134. PubMed ID: 27668530
[TBL] [Abstract][Full Text] [Related]
9. [Bone scintigraphy for diagnosis of bone metastasis in patients with prostatic cancer].
Nakashima J
Nihon Rinsho; 2002 Dec; 60 Suppl 11():135-9. PubMed ID: 12599559
[No Abstract] [Full Text] [Related]
10. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
Takahashi S
Clin Calcium; 2006 Apr; 16(4):581- 90. PubMed ID: 16582508
[TBL] [Abstract][Full Text] [Related]
11. Serum markers of cutaneous melanoma.
Perrotta R; Bevelacqua Y; Malaguarnera G; Paladina I; Giordano M; Malaguarnera M
Front Biosci (Elite Ed); 2010 Jun; 2(3):1115-22. PubMed ID: 20515782
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma--markers for progression and prognosis in malignant melanoma.
Geilen CC; Georgieva J; Milling A; Farthmann B
Front Radiat Ther Oncol; 2006; 39():120-126. PubMed ID: 16394675
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]